298 related articles for article (PubMed ID: 24439237)
1. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study.
Pietersen E; Ignatius E; Streicher EM; Mastrapa B; Padanilam X; Pooran A; Badri M; Lesosky M; van Helden P; Sirgel FA; Warren R; Dheda K
Lancet; 2014 Apr; 383(9924):1230-9. PubMed ID: 24439237
[TBL] [Abstract][Full Text] [Related]
2. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
Dheda K; Shean K; Zumla A; Badri M; Streicher EM; Page-Shipp L; Willcox P; John MA; Reubenson G; Govindasamy D; Wong M; Padanilam X; Dziwiecki A; van Helden PD; Siwendu S; Jarand J; Menezes CN; Burns A; Victor T; Warren R; Grobusch MP; van der Walt M; Kvasnovsky C
Lancet; 2010 May; 375(9728):1798-807. PubMed ID: 20488525
[TBL] [Abstract][Full Text] [Related]
3. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.
Dheda K; Limberis JD; Pietersen E; Phelan J; Esmail A; Lesosky M; Fennelly KP; Te Riele J; Mastrapa B; Streicher EM; Dolby T; Abdallah AM; Ben-Rached F; Simpson J; Smith L; Gumbo T; van Helden P; Sirgel FA; McNerney R; Theron G; Pain A; Clark TG; Warren RM
Lancet Respir Med; 2017 Apr; 5(4):269-281. PubMed ID: 28109869
[TBL] [Abstract][Full Text] [Related]
4. High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis.
Pietersen E; Peter J; Streicher E; Sirgel F; Rockwood N; Mastrapa B; Te Riele J; Davids M; van Helden P; Warren R; Dheda K
PLoS One; 2015; 10(4):e0123655. PubMed ID: 25909847
[TBL] [Abstract][Full Text] [Related]
5. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality.
Gandhi NR; Shah NS; Andrews JR; Vella V; Moll AP; Scott M; Weissman D; Marra C; Lalloo UG; Friedland GH;
Am J Respir Crit Care Med; 2010 Jan; 181(1):80-6. PubMed ID: 19833824
[TBL] [Abstract][Full Text] [Related]
6. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.
Yuengling KA; Padayatchi N; Wolf A; Mathema B; Brown T; Horsburgh CR; OʼDonnell MR
J Acquir Immune Defic Syndr; 2018 Dec; 79(4):474-480. PubMed ID: 30212394
[TBL] [Abstract][Full Text] [Related]
7. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.
Gandhi NR; Moll A; Sturm AW; Pawinski R; Govender T; Lalloo U; Zeller K; Andrews J; Friedland G
Lancet; 2006 Nov; 368(9547):1575-80. PubMed ID: 17084757
[TBL] [Abstract][Full Text] [Related]
8. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
Nkurunziza J; Karstaedt AS; Louw R; Padanilam X
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319
[TBL] [Abstract][Full Text] [Related]
10. Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa.
Olayanju O; Limberis J; Esmail A; Oelofse S; Gina P; Pietersen E; Fadul M; Warren R; Dheda K
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29700106
[TBL] [Abstract][Full Text] [Related]
11. Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.
Ndjeka N; Conradie F; Schnippel K; Hughes J; Bantubani N; Ferreira H; Maartens G; Mametja D; Meintjes G; Padanilam X; Variava E; Pym A; Pillay Y
Int J Tuberc Lung Dis; 2015 Aug; 19(8):979-85. PubMed ID: 26162365
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
13. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS
Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066
[TBL] [Abstract][Full Text] [Related]
15. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.
O'Donnell MR; Padayatchi N; Kvasnovsky C; Werner L; Master I; Horsburgh CR
Emerg Infect Dis; 2013 Mar; 19(3):416-24. PubMed ID: 23622055
[TBL] [Abstract][Full Text] [Related]
17. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.
Padayatchi N; Gopal M; Naidoo R; Werner L; Naidoo K; Master I; O'Donnell MR
J Antimicrob Chemother; 2014 Nov; 69(11):3103-7. PubMed ID: 24986495
[TBL] [Abstract][Full Text] [Related]
18. Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa.
Shean K; Streicher E; Pieterson E; Symons G; van Zyl Smit R; Theron G; Lehloenya R; Padanilam X; Wilcox P; Victor TC; van Helden P; Grobusch MP; Warren R; Badri M; Dheda K
PLoS One; 2013; 8(5):e63057. PubMed ID: 23667572
[TBL] [Abstract][Full Text] [Related]
19. Survival from XDR-TB is associated with modifiable clinical characteristics in rural South Africa.
Shenoi SV; Brooks RP; Barbour R; Altice FL; Zelterman D; Moll AP; Master I; van der Merwe TL; Friedland GH
PLoS One; 2012; 7(3):e31786. PubMed ID: 22412840
[TBL] [Abstract][Full Text] [Related]
20. Survival and predictors of outcomes in non-HIV-infected patients with extensively drug-resistant tuberculosis.
Jeon DS; Kim DH; Kang HS; Hwang SH; Min JH; Kim JH; Sung NM; Carroll MW; Park SK
Int J Tuberc Lung Dis; 2009 May; 13(5):594-600. PubMed ID: 19383192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
